Management (control) of early bladder lesions

The National Bladder Cancer Group's experience: invasive and metastatic bladder cancer selected reports.

Seminars in urologic oncology·2001

Bladder cancer: race differences in extent of disease at diagnosis.

Cancer·2000

Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group.

The Journal of urology·1992

13-cis-retinoic acid in chemoprevention of superficial bladder cancer. The National Bladder Cancer Group.

Journal of cellular biochemistry. Supplement·1992

The usefulness of serum acid phosphatase in monitoring patients with advanced prostate carcinoma.

Advances in experimental medicine and biology·1992

Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1991

Transcriptomic Profiling of Mouse Mammary Tumors Enables Prognostic and Predictive Biomarker Discovery for Human Breast Cancer.

Cancer research·2026

RASA2 Promotes Pancreatic Cancer Metastasis by Activating TGFβ-Dependent Non-canonical Hedgehog Signaling.

Cancer research·2026

KRASG12V Degraders Provide a Potential Therapeutic Opportunity in Lung Adenocarcinoma.

Cancer research·2026

Aberrant O-glycosylation Induces IL-34-Mediated Immune Remodeling and Promotes Pancreatic Cancer Progression.

Cancer research·2026

Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer.

Cancer research·2026

Spatial Profiling Reveals Immune Escape Pathways and Therapeutic Vulnerabilities in Prostate Cancer Bone Metastases.

Cancer research·2026

Synergistic cell-cycle repression by HDAC/EZH2 co-targeting in H3K27-altered diffuse midline glioma.

Molecular therapy. Oncology·2026

In-depth characterization of stem cell potency and genotoxicity for clinical-scale ex vivo CRISPR-Cas9 gene editing.

Molecular therapy. Advances·2026

m6A-dependent regulation of DGUOK-AS1 by RBM15 and HNRNPH1 in lung adenocarcinoma.

iScience·2026

Metabolic reprogramming in pancreatic cancer: interplay of glucose, lipid, and amino acid metabolism in tumor progression.

Cytotechnology·2026

Baicalein targets the Nrf2/Keap1 interaction and related stress pathways to mitigate drug-induced toxicity and reverse resistance in breast cancer: A review.

International journal of biological macromolecules·2026

Exosomes as next-generation drug carriers: Transforming cancer therapy.

Journal of controlled release : official journal of the Controlled Release Society·2026

Related Experiment Videos

Management (control) of early bladder lesions

Related Concept Videos

The National Bladder Cancer Group's experience: invasive and metastatic bladder cancer selected reports.

Bladder cancer: race differences in extent of disease at diagnosis.

Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group.

13-cis-retinoic acid in chemoprevention of superficial bladder cancer. The National Bladder Cancer Group.

The usefulness of serum acid phosphatase in monitoring patients with advanced prostate carcinoma.

Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy.

Transcriptomic Profiling of Mouse Mammary Tumors Enables Prognostic and Predictive Biomarker Discovery for Human Breast Cancer.

RASA2 Promotes Pancreatic Cancer Metastasis by Activating TGFβ-Dependent Non-canonical Hedgehog Signaling.

KRASG12V Degraders Provide a Potential Therapeutic Opportunity in Lung Adenocarcinoma.

Aberrant O-glycosylation Induces IL-34-Mediated Immune Remodeling and Promotes Pancreatic Cancer Progression.

Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer.

Spatial Profiling Reveals Immune Escape Pathways and Therapeutic Vulnerabilities in Prostate Cancer Bone Metastases.

Synergistic cell-cycle repression by HDAC/EZH2 co-targeting in H3K27-altered diffuse midline glioma.

In-depth characterization of stem cell potency and genotoxicity for clinical-scale ex vivo CRISPR-Cas9 gene editing.

m6A-dependent regulation of DGUOK-AS1 by RBM15 and HNRNPH1 in lung adenocarcinoma.

Metabolic reprogramming in pancreatic cancer: interplay of glucose, lipid, and amino acid metabolism in tumor progression.

Baicalein targets the Nrf2/Keap1 interaction and related stress pathways to mitigate drug-induced toxicity and reverse resistance in breast cancer: A review.

Exosomes as next-generation drug carriers: Transforming cancer therapy.

Related Experiment Videos

Management (control) of early bladder lesions

Related Concept Videos

Related Articles